Degania Medical degania-medical.com


Degania Medical has six state-of-the-art production facilities and is one of the world's leading groups specializing in the supply of indwelling medical catheters, silicone medical products and medical devices for critical care and operating rooms.

Degania Medical has six state-of-the-art production facilities and is one of the world's leading groups specializing in the supply of indwelling medical catheters, silicone medical products and medical devices for critical care and operating rooms.

Company (Acquired)

Phone:

Fax:



Degania Bet, 1513000
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Degania Medical $0M Nov 28, 2016
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Degania Medical Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors

Competitors

Company Status Description Investors

medSage Technologies

Pittsburgh, Pennsylvania, United States
AcquiredmedSage Technologies aims to provide software and services which enable providers in the Home Medical Equipment (HME) industry to increase supply revenue from current patients by identifying those who require replacement supplies.Login to see details

Cerus Corporation

Concord, California, United States
IPO / Went publicCerus Corporation is a biomedical products company focused on commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System is designed to inactivate blood-borne pathogens in donated blood components intended for transfusion. Cerus currently markets the INTERCEPT Blood System for both platelets and plasma in Europe, Russia, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is currently in clinical develo...Show allLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)